Most people with Long Covid experience gradual improvement over twelve to twenty-four months, according to a 2025 study. However, approximately 17% may have persistent symptoms or worsening conditions. Understanding individual variations and biological factors is crucial, as ongoing research aims to develop targeted therapies. Avoiding reinfection is also essential for recovery.
Tag: long covid research
When the Eyes and Ears Are Normal but the Symptoms Persist
Many Covid recovery patients experience tinnitus, visual disturbances, and sensory dysregulation, often without structural abnormalities in tests. These symptoms suggest central nervous system involvement rather than local issues. While no targeted treatment exists, managing autonomic function and avoiding sensory overload may stabilize symptoms, reflecting a broader neurological pattern in Long Covid.
Immunotherapies and Monoclonal Antibodies in Long Covid: Evidence, Trials, and Clinical Uncertainty
Long Covid presents a complex challenge for clinicians, as many patients exhibit a variety of persistent symptoms suggestive of immune dysregulation. Growing interest in immunotherapies and monoclonal antibodies highlights potential benefits for certain subsets of patients. However, evidence remains limited, necessitating caution and careful patient selection in treatment approaches.
Navigating Life’s Challenges Post-COVID
Life is divided between those who have moved on from COVID and those with long COVID, facing daily struggles. Small achievements feel monumental, while society neglects the ongoing crisis. Advocating for ourselves and supporting each other is vital as we navigate fatigue and isolation, striving for recognition and change. Hope lies in community and shared victories.
Long COVID: Communities Changing the Healthcare Narrative
Recent years have seen a paradigm shift in healthcare dynamics, especially for conditions like Long COVID. Social media empowers patients to organize, advocate, and lead research efforts, fostering peer support and amplifying their voices. This democratization of knowledge influences research agendas, policy discussions, and challenges traditional medical narratives, creating a collaborative future in medicine.
Long COVID in Children: What Parents and Doctors Need to Know
Long COVID affects children, leading to persistent symptoms like fatigue and brain fog, regardless of the initial illness severity. The First International Meeting on Paediatric Long COVID in Rome, November 2024, brought experts together to address this issue, sharing insights on biological causes, treatment strategies, and the need for tailored care to support affected families.
Role of Galectin-3 in Long COVID Symptoms
Prof. Resia Pretorius and Dr. Douglas Kell's research reveals why long COVID can induce blood clotting issues, focusing on abnormal clots and the protein galectin-3. Their findings suggest potential treatments, such as targeting galectin-3 and repurposing amyloid therapies, while emphasizing the need for further study on long COVID's implications for millions affected.
Long COVID Daily Life: Living in a World That Moved On
Introduction Living with Long COVID daily life does not feel like recovery. It feels like being left behind. There is the world outside, where people have moved on, stopped thinking about COVID, and returned to normal routines. And then there is your world, where every decision still revolves around energy, symptoms, and risk. From the … Continue reading Long COVID Daily Life: Living in a World That Moved On
Long COVID: The Real, Invisible Challenge
Long COVID is a serious, physical condition that goes beyond ordinary fatigue, impacting daily life. It manifests as debilitating symptoms like extreme tiredness, brain fog, and unpredictable energy levels. Society's misunderstanding creates stigma, hindering support. Increased research, accessible treatments, and medical training are crucial for proper recognition and care for those affected.